Ginsenoside Compound K (CK) and its analogues have garnered significant attention in recent years for their potential therapeutic effects in managing metabolic diseases. This article explores the bioconversion processes of ginsenosides into CK, the pharmacokinetic properties of CK and its analogues and the underlying therapeutic mechanisms implicated in treating metabolic diseases such as diabetes, obesity and hyperlipidemia. Understanding these aspects is crucial for developing effective therapeutic strategies harnessing the potential of ginsenoside CK and its derivatives.
HTML PDFShare this article
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report
